Herpes Simple tipo 1 en pacientes pediátricos y su tratamiento. Revisión Bibliográfica
Herpes Simplex type 1 (HSV-1) is a nuclear replicating enveloped virus, usually acquired through direct contact with infected lesions (typically saliva), belonging to the herpesviridiae family, this type of lesions are asymptomatic and after the incubation period are characterized by blistering vesi...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | bachelorThesis |
| اللغة: | spa |
| منشور في: |
2022
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://dspace.unl.edu.ec/jspui/handle/123456789/25750 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
إضافة وسم | الملخص: | Herpes Simplex type 1 (HSV-1) is a nuclear replicating enveloped virus, usually acquired through direct contact with infected lesions (typically saliva), belonging to the herpesviridiae family, this type of lesions are asymptomatic and after the incubation period are characterized by blistering vesicle lesions that increase progressively from childhood, especially in children 6 months to 5 years of age, therefore giving rise to a spectrum of clinical manifestations that concern the development of a primary herpetic Gingivostomatitis for which it is distributed endemically throughout the world. In most cases of infections, outpatient treatment is sufficient, but hospital admission may be warranted if the patient develops complications. The following bibliographical study was carried out with the objective of publicizing the treatment therapies for Herpes Simplex type 1 infection in pediatric patients. The type of study was documentary, descriptive, and analytical, in which the sample consisted of 45 scientific articles in English and Spanish, under the inclusion and exclusion criteria obtained from the PubMed, Elsevier and academic Google databases, which were organized and analyzed according to the stated objectives. It was possible to identify that the most efficient therapy against an infection caused by herpes simplex virus type 1 in children is acyclovir, in addition, it was shown that the ideal dose of acyclovir in pediatric patients is 20 mg/kg 3 times a day |
|---|